In addition, suppressed cell death of dopaminergic neurons in a Parkinson’s disease animal model [24,25], prevention of atherosclerosis in an apolipoprotein E knockout (apoE KO) mouse [26], and suppressed mild cognitive impairment in a dementia animal model [27] provide supporting evidence for in vivo effects. This evidence concerns the gene APOE and Parkinson disease.